Prediction of Cancer Incidence and Mortality in Korea, 2011

Article information

Abstract

Introduction

Having been the leading cause of death since 1983 [1], cancer has become a major public health concern in Korea. Annually, over 170,000 patients are newly diagnosed with cancer in Korea and one out of four deaths is due to cancer [2,3]. While the cancer registration system in Korea is very efficient and can provide the nationwide cancer statistics within a relatively short time, at least a 2-year lag time behind the current year is still needed because of the time required for data collection and compilation. In order to plan and apply a cancer control program for the current year, it is important to assess the number of new cancer cases and cancer deaths that are expected to occur during the current year. In this report, we provide the projected cancer incidence and mortality on the basis of observed data of up to year 2008.

Materials and Methods

The Korea Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry (the Korea Central Cancer Registry [KCCR]) in 1980. The details of the history, objectives, and activities of the KCCR have been documented [4]. Incidence data from 1999-2008 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [5] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [6].

Mortality data from 1993-2009 were obtained from the Korea National Statistics Office (KNSO) [1]. The cause of death was coded and classified according to ICD-10.

The cancer sites included in this report are all cancers combined and 22 common cancers: lip, mouth, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), lung and bronchus (lung) (C33-C34), breast (C50), uterine cervix (C53), uterine corpus (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95), and all others.

The population data were obtained from the resident registration population at the KNSO. The mid-year population on July 1 of the respective year was applied when computing the incident cases, deaths, and rates.

Because the most recent year for which incidence and mortality data are available is usually 2-3 years behind the current year due to the time required for the data collection and analysis, we projected the expected number of new cancer cases and deaths in Korea of the current year to provide an estimate of the current cancer burden.

Linear regression models [7] were used to assess the time trend and the projection of rates. Based on the observed cancer incidence data, a linear regression model was fitted to the age-specific rates by 5-year age group against years. From the projected age-specific rates in 2011, the number of estimated cancer incident cases was calculated by multiplying the rates by age-specific population size in 2011. For thyroid and prostate cancer that showed significant curve-linear trends, we used a square root transformation when fitting a linear regression model and converted the predicted values back to the original scale.

To estimate the number of cancer deaths in 2011, we first ran a Joinpoint regression model on the data from 1993-2009 to detect the year of significant changes in the trend of cancer mortality separately by sex and cancer site. A Joinpoint regression describes the changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using Joinpoint software (version 3.3, http://srab.cancer.gov/joinpoint) from the Surveillance Research Program of the National Cancer Institute in the US [8]. After identifying the year of significant trend changes from a Joinpoint regression analysis, a simple linear regression model was fitted to the last line segment to estimate age-specific cancer mortality rates in 2011. Similar to the method used for the projection of cancer incidence, the number of new deaths was then projected by multiplying the age-specific cancer mortality rates by respective age-specific population.

We summarized the results using the crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. The ASRs were standardized using the World Health Organization (WHO) world standard population [9].

Results

1. Incidence

Table 1 presents the estimated number of new cancer cases and deaths during 2011 in Korea by sex and cancer site. It is projected that 216,809 cancer incident cases will occur during the year 2011.

Table 1

Estimated new cancer cases and deaths by sex during 2011 in Korea

Table 2 presents the estimated CRs and ASRs of cancer incidence in 2011 by sex and cancer site. The CRs of all sites combined in 2011 are projected to be 437.9 and 420.5 per 100,000 in men and women, respectively, and the ASRs of all sites combined are projected to be 336.5 and 279.7 per 100,000. In males, the five leading primary sites of cancer are expected to be the stomach (CR, 83.3; ASR, 62.9), colon and rectum (CR, 71.4; ASR, 54.2), lung (CR, 61.2; ASR, 47.3), liver (CR, 49.2; ASR, 36.6), and prostate (CR, 37.6; ASR, 29.5), accounting for 69.1% of all newly diagnosed cancers in 2011. In females, the most common cancer sites are expected to be thyroid (CR, 128.4; ASR, 92.5), breast (CR, 60.9; ASR, 42.2), colon and rectum (CR, 46.4; ASR, 28.4), stomach (CR, 39.5; ASR, 24.4), lung (CR, 25.4; ASR, 14.5), and liver (CR, 16.8; ASR, 10.2), accounting for 75.5% of all newly diagnosed cancers (Fig. 1). Thyroid cancer alone is projected to account for 30.5% (32,363 cases) of incident cases in women in 2011.

Table 2

Estimated crude and age-standardized cancer incidence rates by sex during 2011 in Korea

Fig. 1

Ten leading cancer types for the estimated new cancer cases and deaths by sex in 2011. (A) Estimated new cases. (B) Estimated deaths.

Table 3 presents the most common cancer sites expected in 2011 by sex and age group. Leukemia and thyroid cancer will be the most common forms of cancer in both sexes 0-14 and 15-34 years of age, respectively. Gastric cancer is predicted to be the most common cancer in males 35-64 years of age, while lung cancer is predicted to be more frequent for males≥65 years of age. The most common sites of cancer will be thyroid for females 35-64 years of age, while colorectal cancer will be the most common cancer for females≥65 years of age.

Table 3

Estimated cancer incidence by age group and sex during 2011 in Korea

Fig. 2 shows the age-specific incidence rates of selected cancers for men and women in 2011. The projection indicates that the incidence of gastric, lung, liver, and colorectal cancers increases gradually with age. In women, the age-specific incidence rates of breast and thyroid cancer will increase with age until the 5th and 6th decades of life, then level off.

Fig. 2

Age-specific cancer incidence rates of major cancers during 2011 in Korea. (A) Male. (B) Female.

2. Mortality

It is estimated that 71,036 cancer deaths will occur during 2011 (Table 1). The CRs of all sites combined in 2011 are projected to become 176.2 and 104.9 per 100,000 for men and women, respectively, and the ASRs of all sites combined are expected to be 136.6 and 58.3 per 100,000 for men and women, respectively (Table 4).

Table 4

Estimated crude and age-standardized cancer mortality rates by sex during 2011 in Korea

In men, the five leading primary cancer sites for mortality in 2011 are predicted to be lung (CR, 45.7; ASR, 41.2), liver (CR, 32.6; ASR, 29.9), stomach (CR, 23.1; ASR, 17.3), colon and rectum (CR, 17.3; ASR, 13.3), and pancreas (CR, 9.2; ASR, 7.3). In women, lung cancer (CR, 16.6; ASR, 9.4) is projected to be the leading cancer site for mortality in 2011, followed by cancers of the colon and rectum (CR, 13.4; ASR, 7.4), stomach (CR, 12.3; ASR, 9.7), liver (CR, 10.9; ASR, 7.5), and gallbladder (CR, 7.8; ASR, 4.4).

Fig. 3 shows the age-specific mortality rates of the selected cancers for men and women in 2011. When examined by age, liver cancer is expected to have the highest mortality rates in Korean men up to 60 years of age, followed by lung cancer. In contrast, breast cancer is expected to have the highest mortality rates in Korean women up to 55 years of age, followed by lung cancer.

Fig. 3

Age-specific cancer mortality rates of major cancers during 2011 in Korea. (A) Male. (B) Female.

Conclusion

This report provides the estimated nationwide cancer incidence and mortality in Korea in the current year. There are 216,809 cancer cases and 71,036 cancer deaths expected during 2011 in Korea. In Korean men, gastric, colorectal, lung, liver, and prostate cancers are estimated to be the most common incident cancers, and lung, liver, gastric, colorectal, and pancreatic cancers are estimated to be the most common cancer-related deaths. In Korean women, thyroid, breast, gastric, colorectal, and lung cancer are estimated to be the most common incident cancers and lung, colorectal, stomach, liver, and gallbladder cancers are the most common cancer-related deaths.

Cancer has become an important public health concern in Korea, and as Korea becomes an aged society, the cancer burden will continue to increase. The estimated cancer statistics of the current year in this report can be used as an important source to plan and evaluate the cancer control programs in Korea. The estimates in this report, however, are projected numbers based on statistical models which may vary from year-to-year, hence these estimates should be used with caution.

Article information Continued